9/6/2023 0 Comments European pharmacopoeia freeThe product will be referred to as BNT162b2 in this lay summary for ease of reading.įor practical information about using BNT162b2 patients should read the Information for UK recipients or contact their doctor or healthcare practitioner. Provide practical advice on how to use this product. Of the Human Medicine Regulations, as well as its conditions of use. It explains how this product was assessed and authorised under Regulation 174 This is a summary of the Public Assessment Report ( PAR) for COVID-19 mRNA VaccineīNT162b2. Authorisation for Temporary Supply, COVID-19 mRNA Vaccine BNT162b2 (BNT162b2 RNA) concentrate for solution for injectionĭepartment of Health and Social Care ( DHSC), Pfizer Limited & BioNTech Manufacturing, GmbH Lay summary, COVID-19 mRNA Vaccine BNT162b2 concentrate for solution for injection (BNT162b2 RNA)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |